Why would a child diagnosed with beta thalassemia and hemosiderosis receive deferoxamine (Desferal)?

Questions 53

ATI RN

ATI RN Test Bank

physical assessment test bank Questions

Question 1 of 5

Why would a child diagnosed with beta thalassemia and hemosiderosis receive deferoxamine (Desferal)?

Correct Answer: D

Rationale: In the case of a child diagnosed with beta thalassemia and hemosiderosis, the correct answer is D) To eliminate excessive iron and prevent organ damage. Deferoxamine (Desferal) is a chelating agent used to remove excess iron from the body. Patients with beta thalassemia often require frequent blood transfusions, which can lead to iron overload and hemosiderosis, a condition characterized by the accumulation of iron in tissues and organs. Excessive iron can cause organ damage, particularly to the heart and liver, so the administration of deferoxamine helps to prevent these complications by binding to the excess iron and facilitating its excretion from the body. Option A) To prevent blood transfusion reactions is incorrect because deferoxamine is not used to prevent reactions to blood transfusions, but rather to address iron overload. Option B) To stimulate red blood cell production is incorrect because deferoxamine does not directly stimulate red blood cell production. It is primarily used to chelate excess iron. Option C) To improve the oxygen-carrying capacity of RBCs is incorrect because while iron is essential for oxygen transport in red blood cells, the primary purpose of administering deferoxamine in this context is to address iron overload, not to enhance oxygen-carrying capacity. In an educational context, understanding the rationale behind the use of deferoxamine in patients with beta thalassemia and hemosiderosis highlights the importance of managing iron overload in these individuals to prevent serious complications. It also underscores the significance of pharmacological interventions in addressing specific pathophysiological processes in patients with complex medical conditions.

Question 2 of 5

Which agent is NOT useful in prophylactic treatment of migraine headaches?

Correct Answer: A

Rationale: In the context of pharmacology and migraine treatment, the correct answer, Sumatriptan (Imitrex), is not useful in prophylactic treatment of migraine headaches because it is primarily indicated for acute migraine attacks rather than prevention. Sumatriptan works by constricting blood vessels in the brain and blocking pain pathways, making it more suitable for immediate relief rather than long-term prevention. Amitriptyline (Elavil), Verapamil (Verelan), and Metoprolol (Lopressor) are commonly used in prophylactic treatment of migraines. Amitriptyline, a tricyclic antidepressant, helps regulate neurotransmitter levels in the brain to reduce migraine frequency and severity. Verapamil, a calcium channel blocker, can prevent migraines by relaxing blood vessels. Metoprolol, a beta-blocker, can also be effective in reducing the frequency and intensity of migraines by regulating blood pressure and heart rate. In an educational context, understanding the differences between acute and prophylactic migraine treatments is crucial for healthcare professionals to provide effective care to patients. It is essential for students to grasp the mechanisms of action of various medications to make informed decisions regarding treatment plans and to optimize patient outcomes. By knowing which agents are suitable for prophylactic use in migraine management, healthcare providers can tailor therapy to individual patient needs and improve quality of life for migraine sufferers.

Question 3 of 5

A 65-year-old male presents with findings of symmetric thorax with moderate kyphosis and anterior diameter. Chest expansion is decreased, and the diaphragm is descending 2 cm bilaterally. These findings relate to:

Correct Answer: D

Rationale: The correct answer is D) Chronic obstructive pulmonary disease (COPD). These physical assessment findings are indicative of COPD. The symmetric thorax with moderate kyphosis and increased anterior diameter are typical in COPD patients due to chronic hyperinflation of the lungs. Decreased chest expansion and a descending diaphragm suggest reduced lung function, common in COPD due to air trapping and loss of elastic recoil. Option A) Pneumothorax would present with sudden chest pain and shortness of breath, not gradual changes seen in COPD. Option B) Pleural effusion would typically result in asymmetrical findings and decreased breath sounds. Option C) A fractured rib would cause localized pain and tenderness, not the widespread changes observed in COPD. In an educational context, understanding these physical assessment findings helps healthcare providers differentiate between various respiratory conditions. Recognizing these signs early can lead to prompt diagnosis and appropriate management of COPD, ultimately improving patient outcomes and quality of life.

Question 4 of 5

A patient develops a cough secondary to an angiotensin-converting-enzyme (ACE) inhibitor. The most appropriate statement related to ACE-I cough is that the cough typically:

Correct Answer: A

Rationale: Rationale: The correct answer is A) Resolves within a week after stopping the ACE inhibitor. ACE inhibitors can cause a dry, persistent cough in some patients due to increased bradykinin levels. This cough is a common side effect and typically resolves shortly after discontinuing the medication. Option B) Resolves with splitting the daily dose to twice daily dosing is incorrect because changing the dosing schedule does not address the underlying mechanism of the cough caused by ACE inhibitors. Option C) Occurs with an angiotensin-II receptor blocker (ARB) is incorrect because ARBs work differently from ACE inhibitors and do not typically cause the same cough side effect. Option D) Affects men more than women is incorrect because the incidence of ACE inhibitor-induced cough is not gender-specific. Educational Context: Understanding the side effects of medications like ACE inhibitors is crucial for healthcare professionals to provide safe and effective patient care. Educating patients about potential side effects can improve medication adherence and help manage any adverse reactions promptly. It is important to differentiate between drug-induced coughs and other respiratory issues to provide appropriate interventions.

Question 5 of 5

The typical presentation of severe acute aortic regurgitation (AR) includes sudden severe shortness of breath, rapidly developing heart failure, and:

Correct Answer: B

Rationale: In the context of severe acute aortic regurgitation (AR), the correct answer is B) Chest pain. Severe AR leads to a rapid increase in left ventricular end-diastolic volume, causing left ventricular dilation and increased wall tension. This results in myocardial ischemia and chest pain due to increased oxygen demand and decreased coronary perfusion. Option A) Dry cough is more commonly associated with conditions like heart failure or interstitial lung disease, not specifically with aortic regurgitation. Option C) Decreased blood pressure is a common finding in acute aortic regurgitation due to the sudden volume overload on the left ventricle, but it is not a defining feature of its presentation. Option D) Systolic murmur is a classic finding in aortic regurgitation, but in severe acute cases, the presentation is more focused on the rapid development of heart failure symptoms rather than an audible murmur. In an educational context, understanding the clinical presentation of severe acute aortic regurgitation is crucial for healthcare providers to recognize and manage this life-threatening condition promptly. Recognizing the association of chest pain with severe AR can aid in early diagnosis and intervention to prevent further complications and improve patient outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions